Re: cumulative AUC

From: Ruben Faelens Date: November 08, 2019 technical Source: mail-archive.com
Hi Sam, Can't you simply dose with evid=4 (reset) into your auc compartment (cmt=4)? Op vr 8 nov. 2019 19:09 schreef Sam Liao <[email protected]>: > Dear nmusers, > > I have a question how to reset cumulative AUC in a $DES model, where > DADT(4) is set up as cumulative AUC of C1. > > Because the study is a four way crossover study, the cumulative value of > A(4) need to rest to zero before each subsequent treatments. > > However, NONMEM do not allow setting A(4) to zero in the statement of > control stream. > > Is there any work around of this problem? > > Best regards, > > Sam Liao
Quoted reply history
> On 11/7/2019 7:17 AM, Farrell, Colm wrote: > > At ICON, it’s our people that set us apart. > > As a global provider of drug development solutions, our work is serious > business. But that doesn’t mean you can’t have fun while you do it. With > our vision to be the partner of choice in drug development, we hire only > the best and brightest in the industry. Are you one of them? > > Due to the continuing demand to support our clients in drug development > through the integration of modelling and simulation into clinical > development programs, ICON is looking for an experienced pharmacometrician > to join our global PKPDM&S team, with a key responsibility to develop and > apply M&S strategies, study designs and analyses across all phases of drug > development. With members of the PKPDM&S based in UK and USA, we’re > flexible on the location. > > *The role* > > · Prepare PKPDM&S-based strategies to support clinical > development programs; > > · Design, conduct, interpret and prepare appropriate study and > regulatory summaries of PKPDM&S activities; > > · Build and sustain great relationships with clients; > > · Prepare and present scientific publications; > > · Serve as scientific reviewer and staff mentor to colleagues. > > *What you need* > > · PhD (or equivalent experience) in pharmacokinetics/PKPD with > proven industry or academic post PhD experience; > > · Excellent understanding of the integration of PKPDM&S into > clinical drug development > > · Demonstrated expertise in hands-on population-based modelling > e.g. NONMEM, Monolix and related software (R, Xpose, PsN); > > · Proven mentorship capabilities. > > *Why join us* > > ICON enjoys a strong reputation for quality and is focused on staff > development. We make it our mission to attract the most diverse and > creative minds into the business and we continually strive to provide > opportunities for our people to excel, grow and build a phenomenal career. > We understand that our greatest asset is the skills and talents of our > people and they are truly what set us apart. Other than working with a > great team of switched on and ambitious people, we also offer a very > competitive benefits package. This varies from country to country so a > dedicated recruiter will discuss this with you at interview stage. We care > about our people as they are the key to our success. We provide an open and > friendly work environment where we empower people and provide them with > opportunities to develop their long term career. ICON is an equal > opportunity employer - M/F/D/V and committed to providing a workplace free > of any discrimination or harassment. > > To find out more and apply for the role, please visit: > https://icon.wd3.myworkdayjobs.com/broadbean_external/job/UK-London-Marlow/Senior-PK-Scientist-II_061382-1 > > > > >
Nov 08, 2019 Sam Liao cumulative AUC
Nov 08, 2019 Rob ter Heine Re: cumulative AUC
Nov 08, 2019 Rob ter Heine Re: cumulative AUC
Nov 08, 2019 Leonid Gibiansky Re: cumulative AUC
Nov 08, 2019 Ruben Faelens Re: cumulative AUC
Nov 08, 2019 Matt Fidler Re: cumulative AUC
Nov 20, 2019 Dongfen Yuan RE: cumulative AUC